Skip to main content

Carmen Espejo Ruiz

I am a senior researcher at the Vall d'Hebron Research Institute since 2014. I develop my research activity in the Clinical Neuroimmunology group – Center d'Esclerosi Múltiple de Catalunya and my main scientific interest is the study of the pathogenesis of multiple sclerosis with the aim to develop new therapeutic strategies.

Institutions of which they are part

Main researcher
Clinical Neuroimmunology
Vall Hebron Institut de Recerca

Carmen Espejo Ruiz

Institutions of which they are part

Main researcher
Clinical Neuroimmunology
Vall Hebron Institut de Recerca

I am a senior researcher at the Vall d'Hebron Research Institute since 2014. I develop my research activity in the Clinical Neuroimmunology group – Center d'Esclerosi Múltiple de Catalunya and my main scientific interest is the study of the pathogenesis of multiple sclerosis with the aim to develop new therapeutic strategies.

I obtained my degree in Biology from the University of Barcelona in 1998. I did my doctoral thesis at the Clinical Neuroimmunology Unit of the Hospital Universitari Vall d'Hebron, in which I studied the role of metallothioneins in the pathogenesis of multiple sclerosis, obtaining my PhD in Biology from the University of Barcelona in 2005. In 2008, I got a Miguel Servet contract that allowed me to establish myself as principal investigator of the Clinical Neuroimmunology group – Multiple Sclerosis Centre of Catalonia. Currently, I am a senior researcher at the Vall d'Hebron Research Institute and develop my scientific activity in the Clinical Neuroimmunology group - Center d'Esclerosi Múltiple de Catalunya.
My main scientific interest is the study of the pathogenesis of multiple sclerosis with the aim of developing new therapeutic strategies. I am currently focused on the role of immunosenescence in the pathogenesis of multiple sclerosis and the therapeutic potential of different senolytic drugs. I am also studying how the modification of the gut microbiota, through the administration of probiotics, could constitute a therapeutic tool in multiple sclerosis. Finally, I am carrying out a project that aims to induce immune tolerance, through the use of nanomedicine, with the aim of slowing down the autoimmune response in multiple sclerosis. I have more than 25 years of experience in animal models of multiple sclerosis and in the study of the immune response.
At the Vall d'Hebron Research Institute, I am a member (since 2003) and the president (since 2006) of the Animal Experimentation Ethics Committee. I am also part of the Biosafety Committee (since 2015) and the Research Integrity Committee (since 2020).
I have participated, as main or collaborating author, in 70 publications indexed in peer review journals. I have supervised eight doctoral theses and eight master's final projects. In addition, I participated as a teacher in various training activities, including the Master of Advanced Immunology at the Autonomous University of Barcelona and the University of Barcelona.

Projects

Estabilització - Neuroimmunologia clínica

IP: Carmen Espejo Ruiz
Collaborators: Miriam Izquierdo Sans
Funding agency: Instituto de Salud Carlos III
Funding: 121500
Reference: CPII13/00028
Duration: 01/04/2014 - 31/03/2017

Las proteínas morfogenéticas óseas como posibles biomarcadores en la esclerosis múltiple: expresión en lesiones y líquido cefalorraquídeo de pacientes con esclerosis múltiple

IP: Carmen Espejo Ruiz
Collaborators: Herena Eixarch Ahufinger, Georgina Arrambide García, Mar Tintore Subirana, Elena Antima Martinez Saez
Funding agency: Fundación Merck Salud
Funding: 25000
Reference: SERONO-2013-04
Duration: 01/05/2014 - 01/11/2016

El antagonismo de la señalización de las "bone morphogenic proteins" (BMP) como diana para potenciar la neuroregeneración en la esclerosis múltiple

IP: Carmen Espejo Ruiz
Collaborators: Ingrid Galán Cartaña, Carmen Tur Gomez, Herena Eixarch Ahufinger, Elena Antima Martinez Saez, Mireia Castillo Juarez
Funding agency: Instituto de Salud Carlos III
Funding: 103455
Reference: PI12/02144
Duration: 01/01/2013 - 30/06/2017

Red Española de Esclerosis Múltiple

IP: Red Española de Esclerosis Múltiple
Collaborators: Susana Otero Romero, Carlos Nos Llopis, Red Española de Esclerosis Múltiple, Jaume Sastre Garriga, Jordi Rio Izquierdo, Fco. Javier Aymerich Martínez, Ingrid Galán Cartaña, Rosalia Horno Ocaña, Manuel Comabella Lopez, Carmen Tur Gomez, Cristina Auger Acosta, Herena Eixarch Ahufinger, Montserrat Moreno Sánchez, Alex Rovira Cañellas, Red Española de Esclerosis Múltiple, M Jesus Arevalo Navines, Carmen Espejo Ruiz, Angela Vidal Jordana, Joaquin Castillo Justribo, Mireia Castillo Juarez, Nicolás Miguel Fissolo
Funding agency: Instituto de Salud Carlos III
Funding: 198090
Reference: RD12/0032/0017
Duration: 01/01/2013 - 31/12/2016

Related news

A study conducted at the Catalan Multiple Sclerosis Centre (Cemcat) shows that the lack of a reduction in neurofilament light chain during the first year of treatment is associated with a higher risk of subsequent disease activity.

The project’s 4th annual meeting was recently held as part of the Fortalece–Salud programme of the Carlos III Health Institute.

An international study led by researchers from Vall d’Hebron shows that simple tests that patients can perform themselves help detect changes in disability that may occur even in the absence of disease relapses.

Related professionals

Dario Fabian Gándara Sabatini

Dario Fabian Gándara Sabatini

Administration and Management
Neurotraumatology and Neurosurgery Research Unit (UNINN)
Read more
Elena Nogales Torres

Elena Nogales Torres

Administration and Management
Multidisciplinary Nursing Research Group
Read more
Amador Garcia  Ruiz de Gordejuela

Amador Garcia Ruiz de Gordejuela

Postdoctoral researcher
General Surgery
Read more
Eric Colome Martin

Eric Colome Martin

Gestió i Administració
General Services and Infrastructures Unit
Infrastructure Coordination
Manager
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.